company

XPHAGE BIOSOLUTIONS AS

7034 TRONDHEIM

Return on Equity
108,01 %
Current Ratio
1,9
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue1 257 000
Net Income364 000
Total Assets596 000
Total Equity337 000
Income (NOK)2022
Revenue1 257 000
Expenditure841 000
Operating Profit416 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax416 000
Tax52 000
Net Income364 000
Balance (NOK)2022
Total Fixed Assets105 000
Total Current Assets491 000
Total Assets596 000
Total Retained Equity87 000
Total Equity337 000
Total Long-Term Debt1 000
Total Current Debt258 000
Total Equity and Debt596 000
Cash flow (NOK)2022
Sales Income1 257 000
Other Income0
Revenue1 257 000
Cost of Goods Sold13 000
Salary Costs518 000
Depreciation21 000
Impairment0
Expenditure841 000
Operating Profit416 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income364 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures105 000
Total Tangible Assets105 000
Total Fiancial Fixed Assets0
Total Fixed Assets105 000
Stock0
Total Investments0
Cash, Bank358 000
Total Current Assets491 000
Total Assets596 000
Total Equity337 000
Short-Term Group Debt0
Total Long-Term Debt1 000
Creditors15 000
Unpaid Taxes138 000
Dividends0
Other Current Debt53 000
Total Current Debt258 000
Total Equity and Debt596 000
Financial indicators2022
Return on Equity108,01 %
Debt-to-Equity Ratio0
Operating Profit Margin33,09 %
Current Ratio1,9
Quick Ratio1,9
Equity Ratio0,57
Gross Profit Margin98,97 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English